en

PRODUCT DETAIL

IMBRUVICA 140 mg filmom obalené tablety

Code 1531D
MA number EU/1/14/945/007
Product Form: tbl flm 28x1x140 mg (blis.PVC/PCTFE/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EL Bruton`s tyrosine kinase (BTK) inhibitors
L01EL01 Ibrutinib
Shelf life: 24
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 27.03.2019
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 12.01.2021
eu-flag.png sk-flag.png